Menu
GWAS Study

Genome-wide genetic investigation of serological measures of common infections.

Rubicz R, Yolken R, Drigalenko E et al.

25758998 PubMed ID
GWAS Study Type
1932 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RR
Rubicz R
YR
Yolken R
DE
Drigalenko E
CM
Carless MA
DT
Dyer TD
KJ
Kent J
CJ
Curran JE
JM
Johnson MP
CS
Cole SA
FS
Fowler SP
AR
Arya R
PS
Puppala S
AL
Almasy L
ME
Moses EK
KE
Kraig E
DR
Duggirala R
BJ
Blangero J
LC
Leach CT
GH
Göring HH
Chapter II

Abstract

Summary of the research findings

Populations and individuals differ in susceptibility to infections because of a number of factors, including host genetic variation. We previously demonstrated that differences in antibody titer, which reflect infection history, are significantly heritable. Here we attempt to identify the genetic factors influencing variation in these serological phenotypes. Blood samples from >1300 Mexican Americans were quantified for IgG antibody level against 12 common infections, selected on the basis of their reported role in cardiovascular disease risk: Chlamydia pneumoniae; Helicobacter pylori; Toxoplasma gondii; cytomegalovirus; herpes simplex I virus; herpes simplex II virus; human herpesvirus 6 (HHV6); human herpesvirus 8 (HHV8); varicella zoster virus; hepatitis A virus (HAV); influenza A virus; and influenza B virus. Pathogen-specific quantitative antibody levels were analyzed, as were three measures of pathogen burden. Genome-wide linkage and joint linkage and association analyses were performed using ~1 million SNPs. Significant linkage (lod scores >3.0) was obtained for HHV6 (on chromosome 7), HHV8 (on chromosome 6), and HAV (on chromosome 13). SNP rs4812712 on chromosome 20 was significantly associated with C. pneumoniae (P=5.3 × 10(-8)). However, no genome-wide significant loci were obtained for the other investigated antibodies. We conclude that it is possible to localize host genetic factors influencing some of these antibody traits, but that further larger-scale investigations will be required to elucidate the genetic mechanisms contributing to variation in antibody levels.

1,932 Mexican American individuals

Chapter III

Study Statistics

Key metrics and study information

1932
Total Participants
GWAS
Study Type
No
Replicated
Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.